© 2024 Virasoft Corporation | Designed by OrBiT 
Once we receive your form, we will contact you for appropriate demo dates.

NEW feature in the latest version of Virasoft’s APLIS, Virapis!

NEW feature in the latest version of Virasoft’s APLIS, Virapis!
NEW feature in the latest version of Virasoft’s APLIS, Virapis! 
A New Era of Synoptic Reporting in Smear Diagnostics: The Bethesda Synoptic Checklist 
This enhancement is designed to standardize smear reports and provide greater accuracy in cytology diagnostics.

find_in_page Key features:

  • Synoptic Bethesda Reporting: Synoptic Bethesda enables the creation of standardized smear reports with a specific format and sections.
  • Personalized Worklists: Positive cases are prioritized and grouped in personalized pathologist worklists.
  • High-Risk Case Alerts: Patients with malignant diagnoses or positive smear results are marked as high-risk in both pathologist and cytotechnologist worklists.
  • Fast and Efficient Reporting: Predefined headings and options allow reports to be prepared more quickly and efficiently. Pathologists and cytotechnologists can mark and report necessary information without delay.
Synoptic Bethesda Reporting
  • Easy-to-Understand Information: The structured format of Synoptic Bethesda enhances clarity in the diagnostic process, making it easier for clinicians and healthcare professionals to interpret the information in the report.
  • Reduced Risk of Errors: A standardized and structured format minimizes the risk of missing information or incorrect reporting. The use of specific headings and options prevents the omission of crucial information.
  • Data Analysis and Research: Synoptic Bethesda allows for the retrospective collection and analysis of reported data, supporting research conducted on large datasets.
  • Integration with Clinical Decision Support Systems: Synoptic Bethesda can be easily integrated with electronic health records and clinical decision support systems, contributing to better decision-making in patient management.